Regional Cerebral Metabolic Alterations in Dementia of the Alzheimer Type: Positron Emission Tomography with [1818] Fluorodeoxyglucose

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Journal of computer assisted tomography

• Publication date

  1983-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00004728-198308000-00003PMID 6602819
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A potential error in modifications of the [14C]2-deoxyglucose technique.

  1983cited by this paper
• Tomographic mapping of human cerebral metabolism: Sensory deprivation

  1982cited by this paper
• Computed tomography findings in senile dementia and normal aging.

  1982cited by this paper
• 18F-2-deoxy-2-fluoro-D-glucose as a tracer in the positron emission tomographic study of senile dementia.

  1982cited by this paper
• Volumetric measurements of the cerebrospinal fluid spaces in demented subjects and controls.

  1982cited by this paper
• EEG and computed tomography in the investigation of patients with senile dementia.

  1982cited by this paper
• Immunostaining of neurofibrillary tangles in Alzheimer's senile dementia with a neurofilament antiserum

  1982cited by this paper
• Study of Cerebral Function with Positron Computed Tomography

  1982cited by this paper
• A post-mortem study of the cholinergic and GABA systems in senile dementia.

  1982cited by this paper
• Changes on computed cranial tomography with aging: intracranial fluid volume.

  1982cited by this paper
• Quantitation in Positron Emission Computed Tomography: 5. Physical–Anatomical Effects

  1981cited by this paper
• A quantitative study of cerebral atrophy in old age and senile dementia.

  1981cited by this paper
• Tomographic mapping of human cerebral metabolism

  1981cited by this paper
• Regional EEG analysis and regional cerebral blood flow in Alzheimer's and Pick's diseases.

  1981cited by this paper
• Quantitative indexes of computed tomography in dementia and normal aging.

  1981cited by this paper
• Cognitive correlates of diffuse cerebral atrophy determined by computed tomography

  1981cited by this paper
• Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography.

  1981cited by this paper
• Computed tomography and aging of the brain.

  1981cited by this paper
• Some morphometric aspects of the brain in senile dementia of the alzheimer type

  1981cited by this paper
• Computerized axial tomograms and dementia in elderly patients.

  1981cited by this paper
• Noninvasive regional cerebral blood flow measurements in dementia.

  1980cited by this paper
• Computed tomography evaluations of brain-behavior relationships in senile dementia of the Alzheimer's type.

  1980cited by this paper
• Pathological verification of ischemic score in differentiation of dementias

  1980cited by this paper
• Positron emission tomography in the study of aging and senile dementia.

  1980cited by this paper
• Computed Tomography in the Elderly 2. Senile Dementia: Diagnosis and Functional Impairment

  1980cited by this paper
• Epileptic patterns of local cerebral metabolism and perfusion in humans determined by emission computed tomography of 18FDG and 13NH3

  1980cited by this paper
• Effects of stroke on local cerebral metabolism and perfusion: Mapping by emission computed tomography of 18FDG and 13NH3

  1980cited by this paper
• Computed Tomography in the Elderly: 1. the Normal Population

  1980cited by this paper
• Neurotransmitter-related enzymes in senile dementia of the Alzheimer type.

  1979cited by this paper
• Mapping of local cerebral functional activity by measurement of local cerebral glucose utilization with [14C]deoxyglucose.

  1979cited by this paper
• Multi-infarct dementia.

  1979cited by this paper
• The [18F]Fluorodeoxyglucose Method for the Measurement of Local Cerebral Glucose Utilization in Mane

  1979cited by this paper
• Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of method

  1979cited by this paper
• Quantitative potentials of dynamic emission computed tomography.

  1978cited by this paper
• Local cerebral glucose utilization in the normal conscious macaque monkey

  1978cited by this paper
• Bihemispheric decreases of regional cerebral blood flow in dementia: Correlation with age‐matched normal controls

  1978cited by this paper
• Speech disturbances in presenile dementia related to local cerebral blood flow abnormalities in the dominant hemisphere.

  1978cited by this paper
• Senile dementia.

  1978cited by this paper
• EEG IN PRESENILE DEMENTIA RELATED TO CEREBRAL BLOOD FLOW AND AUTOPSY FINDINGS

  1977cited by this paper
• RELATION BETWEEN PHYSIOLOGICAL FUNCTION AND ENERGY METABOLISM IN THE CENTRAL NERVOUS SYSTEM

  1977cited by this paper
• THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT 1

  1977cited by this paper
• Cerebral blood flow, oxygen utilization, and blood volume in dementia

  1977cited by this paper
• Distribution of cerebral degeneration in Alzheimer's disease

  1976cited by this paper
• The limbic system in Alzheimer's disease. A neuropathologic investigation.

  1976cited by this paper
• Cognitive Reduction in Presenile Dementia Related to Regional Abnormalities of the Cerebral Blood Flow

  1976cited by this paper
• Cerebral blood flow in dementia.

  1975cited by this paper
• Evidence of subnormal function of association cortex in presenile dementia

  1975cited by this paper
• Regional cerebral blood flow in organic dementia with early onset.

  1970cited by this paper
• Observations on the brains of demented old people.

  1968cited by this paper
• [THE CARBOHYDRATE METABOLISM OF THE HUMAN BRAIN. II. STUDIES WITH SUBSTRATE SPECIFIC ENZYMATIC METHODS IN PATIENTS WITH DIMINISHED CEREBRAL CIRCULATION DUE TO CEREBROVASCULAR ARTERIOSCLEROSIS].

  1964cited by this paper
• THE RELATIONSHIP BETWEEN CLINICAL EVALUATION OF MENTAL DETERIORATION, PSYCHOLOGICAL TEST RESULTS, AND THE CEREBRAL METABOLIC RATE OF OXYGEN

  1964cited by this paper
• Bilateral studies of cerebral oxygen uptake in young and aged normal subjects and in patients with organic dementia.

  1960cited by this paper

• Unraveling the mystery of citrate transporters in Alzheimer's disease: An updated review.

  2025cites this paper
• Exploring glycolytic enzymes in disease: potential biomarkers and therapeutic targets in neurodegeneration, cancer and parasitic infections

  2025cites this paper
• The role of microbiota modulation in preventing Alzheimer’s disease- a review

  2025cites this paper
• The Impact of Exercise on Brain Mitochondrial Health and Its Relevance to Alzheimer's Disease

  2025cites this paper
• Incretin Mimetics as Potential Disease Modifying Treatment for Alzheimer’s Disease

  2024cites this paper
• Elevated blood glucose levels are associated with the progression of brain hypometabolism, and HDL-C and APOE4 add to this association

  2024cites this paper
• PET/CT/MRI in Clinical Trials of Alzheimer’s Disease

  2024cites this paper
• The ADNI PET Core at 20

  2024cites this paper
• Cutting-Edge Strategies for Overcoming Therapeutic Barriers in Alzheimer's Disease.

  2024cites this paper
• Phosphatidylserine: A comprehensive overview of synthesis, metabolism, and nutrition.

  2024cites this paper
• GlyNAC (Glycine and N-Acetylcysteine) Supplementation in Old Mice Improves Brain Glutathione Deficiency, Oxidative Stress, Glucose Uptake, Mitochondrial Dysfunction, Genomic Damage, Inflammation and Neurotrophic Factors to Reverse Age-Associated Cognitive Decline: Implications for Improving Brain He

  2023cites this paper
• Systemic Growth Factor Increases as a Result of Exercise May Reduce Alzheimer's Disease Risk in Midlife Mice and Humans

  2023cites this paper
• Mitochondrial dysfunction in neurodegenerative disorders: Potential therapeutic application of mitochondrial transfer to central nervous system-residing cells

  2023cites this paper
• Brain metabolic network covariance and aging in a mouse model of Alzheimer's disease

  2023cites this paper
• Topological dissimilarities of hierarchical resting networks in type 2 diabetes mellitus and obesity

  2022cites this paper
• Potential for Ketotherapies as Amyloid-Regulating Treatment in Individuals at Risk for Alzheimer’s Disease

  2022cites this paper
• Phosphatidylserine, inflammation, and central nervous system diseases

  2022cites this paper
• Mitochondrial defects in pancreatic beta-cell dysfunction and neurodegenerative diseases: Pathogenesis and therapeutic applications.

  2022cites this paper
• Comparison of performance between an F18-FDG PET normal brain template and a commercial template using the MIMneuro software

  2022cites this paper
• Design, Synthesis, and Preliminary Evaluation of [68Ga]Ga-NOTA-Insulin as a PET Probe in an Alzheimer’s Disease Mouse Model

  2022cites this paper
• Update FDG-PET in der Demenzdiagnostik

  2022cites this paper
• Beyond monoamines: II. Novel applications for PET imaging in psychiatric disorders

  2022cites this paper
• Brain Atrophy and White Matter Damage Linked to Peripheral Bioenergetic Deficits in the Neurodegenerative Disease FXTAS

  2021cites this paper
• Mitochondrial abnormalities in neurological disorders

  2021cites this paper
• The Potential Utility of Prebiotics to Modulate Alzheimer’s Disease: A Review of the Evidence

  2021cites this paper
• Imaging Techniques in Alzheimer’s Disease: A Review of Applications in Early Diagnosis and Longitudinal Monitoring

  2021cites this paper
• Glucose Metabolic Dysfunction in Neurodegenerative Diseases—New Mechanistic Insights and the Potential of Hypoxia as a Prospective Therapy Targeting Metabolic Reprogramming

  2021cites this paper
• Regional uptakes from early-frame amyloid PET and 18F-FDG PET scans are comparable independent of disease state

  2021cites this paper
• Glut1 deficiency syndrome: New and emerging insights into a prototypical brain energy failure disorder

  2021cites this paper
• The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer’s Disease and Parkinson’s Disease

  2020cites this paper
• Positron Emission Tomography

  2020cites this paper
• Mitochondria as a target for neuroprotection: role of methylene blue and photobiomodulation

  2020cites this paper
• Altered Transcriptional Profile of Mitochondrial DNA-Encoded OXPHOS Subunits, Mitochondria Quality Control Genes, and Intracellular ATP Levels in Blood Samples of Patients with Parkinson’s Disease

  2020cites this paper
• MAM and C99, key players in the pathogenesis of Alzheimer's disease.

  2020cites this paper
• Characterization of the Metabolic, Clinical and Neuropsychological Phenotype of Female Carriers of the Premutation in the X-Linked FMR1 Gene

  2020cites this paper
• Metabolomics markers in Neurology: current knowledge and future perspectives for therapeutic targeting

  2020cites this paper
• Donor-Specific Transcriptomic Analysis of Alzheimer's Disease-Associated Hypometabolism Highlights a Unique Donor, Ribosomal Proteins and Microglia

  2020cites this paper
• Alzheimer amyloid-β- peptide disrupts membrane localization of glucose transporter 1 in astrocytes: implications for glucose levels in brain and blood

  2020cites this paper
• Relationships between Mitochondrial Dysfunction and Neurotransmission Failure in Alzheimer’s Disease

  2020cites this paper
• Dietary natural products as epigenetic modifiers in aging-associated inflammation and disease.

  2020cites this paper
• Biomarker Localization, Analysis, Visualization, Extraction, and Registration (BLAzER) Workflow for Research and Clinical Brain PET Applications

  2019cites this paper
• Donor specific transcriptomic analysis of Alzheimer’s disease associated hypometabolism highlights a unique donor, microglia, and ribosomal proteins

  2019cites this paper
• Role of the Blood-Brain Barrier in Central Nervous System Insulin Resistance

  2019cites this paper
• Mitochondrial Dysfunction and Stress Responses in Alzheimer’s Disease

  2019cites this paper
• Vascular Dysfunction in Alzheimer’s Disease: A Prelude to the Pathological Process or a Consequence of It?

  2019cites this paper
• Dysfunctional Mitochondria and Mitophagy as Drivers of Alzheimer’s Disease Pathogenesis

  2019cites this paper
• Plasma cortisol is associated with cerebral hypometabolism across the Alzheimer's disease spectrum.

  2019cites this paper
• Cortisol associated with hypometabolism across the Alzheimer’s disease spectrum

  2019cites this paper
• Regional hypometabolism in the 3xTg mouse model of Alzheimer's disease.

  2019cites this paper
• Mitochondrial dysfunction in Alzheimer's disease: Role in pathogenesis and novel therapeutic opportunities

  2019cites this paper
• Biomarker Localization, Analysis, Visualization, Extraction, and Registration (BLAzER) Methodology for Research and Clinical Brain PET Applications

  2019cites this paper
• Dietary Neuroketotherapeutics for Alzheimer’s Disease: An Evidence Update and the Potential Role for Diet Quality

  2019cites this paper
• Therapeutic strategies for glucose transporter 1 deficiency syndrome

  2019cites this paper
• Functional Connectivity Analysis on Mild Alzheimer's Disease, Mild Cognitive Impairment and Normal Aging using fNIRS

  2018cites this paper
• Mitochondrial Metabolism in Major Neurological Diseases

  2018cites this paper
• Implications of Successful Symptomatic Treatment in Parkinson's Disease for Therapeutic Strategies of Alzheimer's Disease.

  2018cites this paper
• Altered functional connectivity of the default mode network by glucose loading in young, healthy participants

  2018cites this paper
• Longitudinal effects of aging on 18F-FDG distribution in cognitively normal elderly individuals

  2018cites this paper
• Longitudinal effects of aging on 18F-FDG distribution in cognitively normal elderly individuals

  2018cites this paper
• ApoE2-Mediated Neuroprotective Mechanism Through Up-regulation of Glycolysis

  2018cites this paper
• Longitudinal uncoupling of cerebral perfusion, glucose metabolism, and tau deposition in Alzheimer's disease

  2018cites this paper
• p66Shc activation promotes increased oxidative phosphorylation and renders CNS cells more vulnerable to amyloid beta toxicity

  2018cites this paper
• Fluorodeoxyglucose metabolism associated with tau‐amyloid interaction predicts memory decline

  2017cites this paper
• Etude du métabolisme des pyramides du néocortex dans un modèle murin de la maladie d'Alzheimer - voies de signalisations impliquées dans la modulation de l'excitabilité des pyramides du néocortex par la noradrénaline

  2017cites this paper
• Mitochondria and Mitochondrial Cascades in Alzheimer’s Disease

  2017cites this paper
• Biomarkers in Neurodegenerative Diseases.

  2017cites this paper
• APOE&egr;4 impacts up‐regulation of brain‐derived neurotrophic factor after a six‐month stretch and aerobic exercise intervention in mild cognitively impaired elderly African Americans: A pilot study

  2017cites this paper
• A new data analysis approach for measuring longitudinal changes of metabolism in cognitively normal elderly adults

  2017cites this paper
• Comparison of Different Hypotheses Regarding the Spread of Alzheimer’s Disease Using Markov Random Fields and Multimodal Imaging

  2017cites this paper
• Brain energy metabolism and neuroinflammation in ageing APP/PS1-21 mice using longitudinal 18F-FDG and 18F-DPA-714 PET imaging

  2017cites this paper
• Synergistic effects of combined physical activity and brain training on neurological functions

  2017cites this paper
• Regional Cerebral Blood Flow in Mild Cognitive Impairment and Alzheimer's Disease Measured with Arterial Spin Labeling Magnetic Resonance Imaging

  2017cites this paper
• utyrate , neuroepigenetics and the gut microbiome : Can a high fiber iet improve brain health ?

  2016cites this paper
• Single-photon emission tomography.

  2016cites this paper
• The Role of Cerebrospinal Fluid Biomarkers in the Evolution of Diagnostic Criteria in Alzheimer’s Disease: Shortcomings in Prodromal Diagnosis

  2016cites this paper
• Diabetes and Alzheimer's disease crosstalk.

  2016cites this paper
• Biomarkers for the Early Detection and Progression of Alzheimer’s Disease

  2016cites this paper
• Augmented Reality Serious Gaming for Cognitive Health

  2016influential citation
• Quantitative and Functional Magnetic Resonance Imaging Techniques

  2016cites this paper
• Le métabolisme cérébral au cours du vieillissement chez le sujet sain et dans la maladie d’alzheimer

  2016cites this paper
• Alterations in Glucose Metabolism in Alzheimer's Disease.

  2016cites this paper
• Longitudinal Positron Emission Tomography in Preventive Alzheimer's Disease Drug Trials, Critical Barriers from Imaging Science Perspective

  2016cites this paper
• Bioenergetics and metabolism: a bench to bedside perspective

  2016cites this paper
• Alteration of the regional cerebral glucose metabolism in healthy subjects by glucose loading

  2016influential citation
• Plasma Glucose Levels Affect Cerebral 18F-FDG Distribution in Cognitively Normal Subjects With Diabetes

  2016cites this paper
• Tolerability and pharmacokinetics of oxaloacetate 100 mg capsules in Alzheimer's subjects

  2016cites this paper
• Imaging Alzheimer's disease: The evolution of biomarkers

  2015cites this paper
• Transcriptional regulation of N-acetylaspartate metabolism in the 5xFAD model of Alzheimer's disease: evidence for neuron-glia communication during energetic crisis.

  2015cites this paper
• Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer’s Disease Conversion

  2015cites this paper
• Hippocampal-Parietal Memory Network Coherent Spontaneous Activity Identifies a

  2015cites this paper
• Impairment of Energy Metabolism and Vascular Function in Alzheimer’s Disease

  2015cites this paper
• Relationship Between Alzheimer Disease–Like Pattern of 18F-FDG and Fasting Plasma Glucose Levels in Cognitively Normal Volunteers

  2015cites this paper
• A Pilot Study on Clinical and Neuroimaging Characteristics of Chinese Posterior Cortical Atrophy: Comparison with Typical Alzheimer’s Disease

  2015cites this paper
• Drug-induced cerebral glucose metabolism resembling Alzheimer’s Disease: a case study

  2015cites this paper
• Reduced Uptake of 18F-FDG and 15O-H2O in Alzheimer'S Disease-Related Regions after Glucose Loading

  2015cites this paper
• Metabolic Alterations Associated to Brain Dysfunction in Diabetes.

  2015cites this paper
• Early detection of Alzheimer's disease using PiB and FDG PET.

  2014cites this paper
• Relationship between Alzheimer’s disease-like pattern of 18 F-FDG and fasting plasma glucose levels in cognitively normal volunteers

  2014cites this paper
• Imaging Brain Metabolism and Pathology in Alzheimer’s Disease with Positron Emission Tomography

  2014cites this paper
• Redox Status and Aging Link in Neurodegenerative Diseases

  2014cites this paper